Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,399.97
1,053.03
1,233.15
1,266.16
1,216.72
1,218.91
1,137.63
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,399.97
1,053.03
1,233.15
1,266.16
1,216.72
1,218.91
1,137.63
Raw Material Cost
646.61
501.72
462.39
459.87
435.65
420.66
391.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
273.40
288.60
323.15
429.34
315.91
287.51
225.37
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.19
11.90
7.59
5.72
6.47
6.62
4.71
Selling and Distribution Expenses
596.29
494.19
544.62
753.99
518.85
490.92
417.49
Other Expenses
-20.38
-20.37
-16.19
-19.12
-11.91
-14.42
-7.69
Total Expenditure (Excl Depreciation)
1,326.74
1,092.71
1,175.89
1,457.70
1,157.79
1,061.52
961.91
Operating Profit (PBDIT) excl Other Income
73.2
-39.7
57.300000000000004
-191.5
58.9
157.4
175.7
Other Income
66.20
118.16
68.35
2,427.03
114.61
100.03
247.78
Operating Profit (PBDIT)
287.17
227.98
278.10
2,382.36
301.03
351.56
488.57
Interest
14.19
11.90
7.59
5.72
6.47
6.62
4.71
Exceptional Items
-26.29
-34.93
-49.04
-256.91
-21.61
-116.02
27.60
Gross Profit (PBDT)
753.36
551.31
770.75
806.28
781.07
798.26
746.37
Depreciation
147.73
149.50
152.50
146.87
127.50
94.14
65.08
Profit Before Tax
98.95
31.66
68.97
1,972.86
145.45
134.78
446.38
Tax
29.50
10.84
22.03
9.48
55.50
59.54
56.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
93.10
16.70
51.28
1,987.18
129.32
125.55
418.27
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
93.10
16.70
51.28
1,987.18
129.32
125.55
418.27
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-24.49
3.25
-5.45
-27.29
-50.78
-62.21
-28.51
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
68.61
19.95
45.84
1,959.88
78.53
63.34
389.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Reserves
1,651.80
2,038.95
1,924.11
2,464.58
2,149.80
2,295.90
2,210.54
Earnings per share (EPS)
0.16
0.03
0.09
3.37
0.22
0.21
0.7
Diluted Earnings per share
0.16
0.03
0.09
3.37
0.22
0.21
0.7
Operating Profit Margin (Excl OI)
5.23%
-3.77%
4.64%
-15.13%
4.84%
12.91%
15.45%
Gross Profit Margin
17.62%
17.2%
17.96%
167.41%
22.43%
18.78%
44.96%
PAT Margin
6.65%
1.59%
4.16%
156.95%
10.63%
10.3%
36.77%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 32.95% vs -14.61% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 244.72% vs -56.55% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 101.28% vs -47.66% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 19.33% vs 56.58% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Lee's Pharmaceutical Holdings Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
1,399.97
74.37
1,325.60
1,782.44%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,399.97
74.37
1,325.60
1,782.44%
Raw Material Cost
646.61
46.70
599.91
1,284.60%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
273.40
312.09
-38.69
-12.40%
Power Cost
0
0
0.00
Manufacturing Expenses
14.19
0.99
13.20
1,333.33%
Selling and Distribution Expenses
596.29
357.95
238.34
66.58%
Other Expenses
-20.38
12.07
-32.45
-268.85%
Total Expenditure (Excl Depreciation)
1,326.74
838.42
488.32
58.24%
Operating Profit (PBDIT) excl Other Income
73.23
-764.05
837.28
109.58%
Other Income
66.20
124.97
-58.77
-47.03%
Operating Profit (PBDIT)
287.17
-605.96
893.13
147.39%
Interest
14.19
0.99
13.20
1,333.33%
Exceptional Items
-26.29
-2.13
-24.16
-1,134.27%
Gross Profit (PBDT)
753.36
27.67
725.69
2,622.66%
Depreciation
147.73
33.12
114.61
346.04%
Profit Before Tax
98.95
-642.21
741.16
115.41%
Tax
29.50
0.00
29.50
Provisions and contingencies
0
0
0.00
Profit After Tax
93.10
-642.21
735.31
114.50%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
93.10
-642.21
735.31
114.50%
Share in Profit of Associates
0
0
0.00
Minority Interest
-24.49
0.00
-24.49
Other related items
0.00
0.00
0.00
Consolidated Net Profit
68.61
-642.21
710.82
110.68%
Equity Capital
0
0
0.00
Face Value
0.05
0.00
0.00
Reserves
1,651.80
1,263.28
388.52
30.75%
Earnings per share (EPS)
0.16
-1.04
1.20
115.38%
Diluted Earnings per share
0.16
-1.04
1.20
115.38%
Operating Profit Margin (Excl OI)
5.23%
-1,027.34%
0.00
1,032.57%
Gross Profit Margin
17.62%
-818.97%
0.00
836.59%
PAT Margin
6.65%
-863.51%
0.00
870.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 140.00 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 32.95% vs -14.61% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 6.86 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 244.72% vs -56.55% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.10 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 101.28% vs -47.66% in Dec 2023
Annual - Interest
Interest 1.42 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 19.33% vs 56.58% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.23%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






